drug: dexmethylphenidate |
|
|
| Clinical class | anorexiant, antinarcoleptic, psychostimulant, (amphetamine-like) |
| Action | sympathomimetic amine, central nervous system stimulant |
| Chemical class | active d-threo-enantiomer of methylphenidate |
| CSA schedule | II |
| DEA number | none |
| Routes of administration | oral |
| Associated with (substance-related)
|
disorders |
| Availability | prescription |
U.S. Preparations:
- Focalin™
(Novartis) FDA approved for treatment of
: Attention Deficit Hyperactivity Disorder (ADHD)
11.13.2001
U.S. Prescribing information
- Focalin XR™ (Novartis) FDA approved for treatment of
: Attention Deficit Hyperactivity Disorder (ADHD)
in patients 6 years and older 5.26.2005
U.S. Prescribing information